151 – 200 of 312
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele
(
- Contribution to journal › Scientific review
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury
(
- Contribution to journal › Article
-
Mark
Prion-like seeding and nucleation of intracellular amyloid-β
(
- Contribution to journal › Article
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Altered structural network organization in cognitively normal individuals with amyloid pathology
(
- Contribution to journal › Article
-
Mark
Brain alpha-amylase : a novel energy regulator important in Alzheimer disease?
(
- Contribution to journal › Article
- 2017
-
Mark
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(2). p.200-208(
- Contribution to journal › Article
-
Mark
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
(
- Contribution to journal › Article
-
Mark
Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Association between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals : A Longitudinal Descriptive Cohort Study
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
(
- Contribution to journal › Article
-
Mark
Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
(
- Contribution to journal › Article
-
Mark
The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27(
- Contribution to journal › Published meeting abstract
-
Mark
The interactive effect of demographic and clinical factors on hippocampal volume : A multicohort study on 1958 cognitively normal individuals
(
- Contribution to journal › Article
-
Mark
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
(
- Contribution to journal › Article
-
Mark
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition : Evidence for emerging amyloid pathology in alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Exploring dementia management attitudes in primary care : a key informant survey to primary care physicians in 25 European countries
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease.
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Tau pathology distribution in Alzheimer's disease corresponds differentially to cognition-relevant functional brain networks
(
- Contribution to journal › Article
-
Mark
Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study
2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(3). p.393-401(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid in Alzheimer's : A precious tool
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
-
Mark
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Socioeconomic Predictors of the Employment of Migrant Care Workers by Italian Families Assisting Older Alzheimer's Disease Patients : Evidence from the Up-Tech Study
2016) In Journals of Gerontology - Series B Psychological Sciences and Social Sciences 71(3). p.514-525(
- Contribution to journal › Article
-
Mark
Amyloid beta aggregation kinetics : The role of intrinsic and extrinsic factors.
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer's disease patient with presenilin-1 mutation
(
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
(
- Contribution to journal › Article
-
Mark
Preclinical amyloid-β and axonal degeneration pathology in delirium
(
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
(
- Contribution to journal › Article
-
Mark
The endocytic pathway in microglia during health, aging and Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A methodological study of locus coeruleus degeneration in dementing disorders
(
- Contribution to journal › Article
- 2015
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
(
- Contribution to journal › Article
-
Mark
The economic impact of moderate stage Alzheimer's disease in Italy : Evidence from the UP-TECH randomized trial
(
- Contribution to journal › Article
-
Mark
Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer's disease : The issue of diurnal variation
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Charge Dependent Retardation of Amyloid beta Aggregation by Hydrophilic Proteins
(
- Contribution to journal › Article
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article